New Antimicrobials: For the Present and the Future

Fong, I. W.

  • 出版商: Springer
  • 出版日期: 2024-05-26
  • 售價: $6,280
  • 貴賓價: 9.5$5,966
  • 語言: 英文
  • 頁數: 243
  • 裝訂: Quality Paper - also called trade paper
  • ISBN: 3031260805
  • ISBN-13: 9783031260803
  • 海外代購書籍(需單獨結帳)

商品描述

This is a timely and essential companion to the recently published Antimicrobial Resistance in the 21st Century, Second Edition. Antimicrobial resistance is a major threat to global population health, with government reports projecting it could result in over 10 million deaths in the next 35 years. Development of new agents to combat this threat is one of the WHO's top priorities, but in 2017, it conceded that the current drug development pipeline was insufficient to mitigate the threat. This book discusses recent progress and bolster new agent discovery and development, by providing researchers and students who will soon enter the field with a thorough guide to the advancements made in the last decade.
Coverage includes new systemic antimicrobials approved since 2010, with detailed analysis of antibiotics, antivirals, antifungals, and antiparasitics, as well as agents in development for future use. Discussion of each drug will include its chemical nature, pharmacology/pharmacokinetics, antimicrobial spectrum, dosage, adverse reactions, drug interactions, microbial resistance, indications, clinical efficacy compared to older agents, and lists of similar agents with cost comparison. This volume is designed for researchers and students of infectious disease and medical microbiology, as well as clinicians in need of a comprehensive guide to newly developed agents.

商品描述(中文翻譯)

這本書是最近出版的《21世紀抗微生物藥物耐藥性,第二版》的及時且必要的伴侶。抗微生物藥物耐藥性對全球人口健康構成了重大威脅,政府報告預測在未來35年內可能導致超過1000萬人死亡。開發新的藥物來對抗這一威脅是世界衛生組織的首要任務之一,但在2017年,世界衛生組織承認目前的藥物開發管道不足以應對這一威脅。本書討論了最近的進展,並提供了研究人員和即將進入這一領域的學生一個關於過去十年取得的進展的全面指南,以加強新藥物的發現和開發。內容包括自2010年以來獲得批准的新型全身性抗微生物藥物,詳細分析了抗生素、抗病毒藥物、抗真菌藥物和抗寄生蟲藥物,以及未來使用的開發中藥物。對每種藥物的討論將包括其化學性質、藥理/藥代動力學、抗微生物範圍、劑量、不良反應、藥物相互作用、微生物耐藥性、適應症、與舊藥物相比的臨床療效,以及類似藥物的成本比較列表。本書適用於傳染病和醫學微生物學的研究人員和學生,以及需要全面指南來了解新開發藥物的臨床醫生。

作者簡介

Ignatius Fong is the Editor of Springer's Emerging Infectious Diseases of the 21st Century series. He has served as Chief Editor for six books and the sole author for another six books published in the series. He completed his residency training in Internal Medicine at the University of Toronto and as a Fellow in Infectious Diseases at the University of Washington, Seattle. Dr. Fong has published studies concerning a variety of infectious diseases that include therapeutics and pharmacology of antibiotics, AIDS and the treatment of opportunistic infections, mechanistic and treatment studies of mucosal candidiasis, and pathogenic studies on infection and induction of atherosclerosis in animal models. He was Chief of Infectious Diseases at St. Michael's Hospital (Toronto) for 34 years; he is still on staff in Infectious Diseases and is a Professor of Medicine, Department of Medicine at the University of Toronto, Canada.

作者簡介(中文翻譯)

Ignatius Fong 是 Springer 出版社《21世紀新興傳染病》系列的編輯。他曾擔任六本書的主編,並獨自撰寫了另外六本書。他在多倫多大學完成了內科住院醫師培訓,並在華盛頓大學的感染病學研究生院完成了感染病學的研究。Fong 博士發表了多項關於各種傳染病的研究,包括抗生素的治療和藥理學、愛滋病及其機會性感染的治療、黏膜念珠菌病的機制和治療研究,以及動物模型中感染和動脈粥樣硬化誘導的病理研究。他在多倫多聖邁克爾醫院擔任34年的感染病主任,目前仍在感染病科工作,並擔任加拿大多倫多大學醫學系的醫學教授。